A Post-marketing Observational Study of Oral Cholera Vaccine
A Post-marketing Observational Study of Oral Cholera Vaccine
Enrolling by invitation · NCT07300462 · Registry updated 2026-07-10Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Post-marketing Observational Study of Oral Cholera Vaccine | Pathological Conditions, Signs and Symptoms, Signs and Symptoms, Signs and Symptoms, Digestive, diarrheal disease | Enrolling by invitation | Phase 4 | 2026-07-10 | NCT07300462 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Shanghai United Cell Biotechnology Co., Ltd | 1 |
5 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Anhui Provincial Center for Disease Control and Prevention | Hefei | China | 3 |
| Hubei Provincial Center for Disease Control and Prevention | Wuhan | China | 3 |
| Jiangsu Provincial Center for Disease Control and Prevention | Nanjing | China | 1 |
| National Institute for Communicable Disease Control and Prevention, China | Beijing | China | 1 |
| Shandong Provincial Center for Disease Control and Prevention | Jinan | China | 1 |